Masimo is a noninvasive patient monitoring company known for pulse oximetry and other monitoring technologies.
Founded in 1989 by Joe Kiani, Masimo Corporation develops noninvasive monitoring technologies, including Masimo SET pulse oximetry, SedLine brain function monitoring and LiDCO hemodynamic monitoring. Its products serve hospitals, emergency medical services and outpatient settings. The company completed its IPO in August 2007, raising USD 202.6 mn by pricing 11.92 million shares at USD 17 each. Britian Mark is listed as CEO, and its listed location is Neuchatel, Switzerland.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in